RE: Ava6000 2 data releases coming shortly10 May 2026 20:12
A well written review of the current ADC v PDC battle field but do I misunderstand the writer as he/she is forced to admit that previous unconditional support for Bicycle Therapeutics will be made difficult by the irrefutable success of pre|CISION?
"The competitive intensity within the conditionally-activated delivery field, including Bicycle Therapeutics, probody designs, and masked-antibody platforms, means the TSI bar is rising as the metric matures, and the platforms that produce defensible clinical TSI data first will capture the strongest licensing positions."